By Tibby Reas Hinderlie, Communications Officer
Every year, BCAction attends the San Antonio Breast Cancer Symposium (SABCS), the largest annual breast cancer conference in the world bringing together both researchers and clinical practitioners to present and discuss the latest research and practices. We’re there to provide thought leadership and a social justice perspective on the information presented, and to report back to you the latest findings and their implications.
This year’s conference will be entirely virtual and will take place starting tomorrow, December 8th, through Friday, December 11th. It will include four non-stop, 12-hour days jam-packed with the latest updates on treatments and research in the breast cancer field.
And for the four days of SABCS, our former Executive Director Karuna Jaggar will be joining the BCAction staff, to deliver her one-of-kind analysis and fresh takes on featured sessions and research pieces presented at the conference!
Together, our team will be at the virtual conference, to ensure the important questions are lifted up in a space where medical jargon, unfamiliar acronyms, and pharmaceutical profit can take precedence. We’ll continue to ask:
- Does this treatment meaningfully extend overall survival?
- Does this treatment improve quality of life?
- And is this treatment affordable? Who has access to this treatment, and which groups of people are left out?
To follow along with our analysis, follow Breast Cancer Action at @BCAction on Twitter and Karuna at @karunajaggar. Throughout the week and after the conference, we’ll post write-ups on our blog analyzing what was presented. You can review our past writings on SABCS here.
Will you attend SABCS? Let us know so we can keep in contact, and have the chance to “visit” even in the virtual space.
Breast Cancer Action will continue to use our independent, watchdog voice on behalf of people living with and at risk of breast cancer to focus on the systemic issues at the heart of this epidemic and tackle the root causes of this devastating disease.